Skip to main content
Premium Trial:

Request an Annual Quote

ABI and BioVision to Jointly Develop Proteomics Applications for Mass Spectrometers

NEW YORK, May 7 – Applied Biosystems and BioVision have agreed to jointly develop mass spectrometry tools for proteomics applications, the companies said Monday.

BioVision, based in Hannover, Germany, has worked since 1999 with ABI's German subsidiary to test and demonstrate how ABI tools can be applied to proteomics. The expanded collaboration will give BioVision input into the development of new ABI mass spectrometers and associated equipment. 

Under the agreement, the two companies will build a European reference laboratory in Hannover, where BioVision scientists will investigate new techniques for studying proteins using ABI mass spectrometers. In addition, “people who are interested in ABI tools can see them working with new applications,” said a spokeswoman for BioVision.

The companies did not disclose the financial details of the collaboration.

"BioVision has developed some very creative approaches to protein and peptide purification and analysis," Jay Smith, director and product line manager for MALDI-TOF MS and biochromatography at Applied Biosystems, said in a statement. "We see them as a key partner in shaping and developing our next generation of high-throughput tools."

Four year-old BioVision performs differential display analysis of human blood and other body fluids to identify disease markers and drug targets. The company has a research contract with Roche, and a collaboration with Matrix Science, a British developer of software for integrating mass spectrometry with other bioinformatics tools.  
The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.